|Bid||21.70 x 0|
|Ask||22.55 x 0|
|Day's range||21.79 - 22.37|
|52-week range||21.66 - 29.64|
|Beta (3Y monthly)||1.12|
|PE ratio (TTM)||6.72|
|Earnings date||18 Feb. 2019|
|Forward dividend & yield||0.68 (3.04%)|
|1y target est||19.64|
Ansell is set to shut three production facilities in Mexico and South Korea as the protective manufacturer pushes to save $30 million a year by 2020.
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Read More...
Looking at Ansell Limited’s (ASX:ANN) earnings update in June 2018, analyst consensus outlook appear bearish, with earnings expected to decline by -5.1% in the upcoming year against the past 5-year Read More...
Small-cap and large-cap companies receive a lot of attention from investors, but mid-cap stocks like Ansell Limited (ASX:ANN), with a market cap of AU$3.1b, are often out of the spotlight. Read More...
Ansell Limited (ASX:ANN) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In the case Read More...
In June 2018, Ansell Limited (ASX:ANN) released its latest earnings announcement, which revealed that the business benefited from a strong tailwind, leading to a double-digit earnings growth of 16.8%. Below, Read More...
The content of this article will benefit those of you who are starting to educate yourself about investing in the stock market and want to learn about the link betweenRead More...
Ansell Limited (ASX:ANN) shareholders, and potential investors, need to understand how much cash the business makes from its core operational activities, as well as how much is invested back intoRead More...
Ansell has forecast a mixed outlook after reporting a tripling of full-year net profit to $662.4 million, thanks to sale proceeds from its condom business.
Protective gloves and clothing supplier Ansell has lifted its full-year outlook for earnings per share from its continuing businesses and says it is well positioned for growth. Chief executive Magnus Nicolin says Ansell is seeing strong growth in its HyFlex range of industrial gloves and its Gammex surgical gloves as the products are upgraded with new materials and combinations of materials made by Ansell. Ansell also has invested heavily in products for the life sciences and pharmaceutical manufacturing sectors.
Protective gloves and clothing supplier Ansell has lifted its full-year outlook for earnings per share from its continuing businesses to a range of 96 US cents to $US1.06, ($A1.23 to ($A1.37) up from its previous expectation of 91 US cents to $US1.01. Ansell says the lift in guidance relates to the company's share buyback to date and a lower tax expense following US tax reform, plus the group's underlying business is performing in line with original forecasts. Ansell on Monday reported a net profit of $US428.2 million ($A547.97 million) for the six months to December 31 - up more than 500 per cent - after the company benefited from a $US411.5 million gain on the sale of its sexual wellness business.